Citation Impact

Citing Papers

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
2003 Standout
Serum-Soluble B7x Is Elevated in Renal Cell Carcinoma Patients and Is Associated with Advanced Stage
2008 StandoutNobel
ROS stress in cancer cells and therapeutic implications
2004 Standout
Targeting hypoxia in cancer therapy
2011 Standout
Clinical studies of reversal of drug resistance based on glutathione
1998
The emerging role of reactive oxygen species in cancer therapy
2004
Phase I trial of docetaxel, carboplatin, and gemcitabine as first-line therapy for patients with high-risk epithelial tumors of müllerian origin
2003
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
l-S,R-buthionine sulfoximine: historical development and clinical issues
1998
The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor
1997 StandoutNobel
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Ovarian cancer
2014 Standout
2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines
2000
Beyond Cholesterol
1989 Standout
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
2009
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Paclitaxel in cancer therapy
2002
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines
2003
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Spermidine reduces lipid accumulation and necrotic core formation in atherosclerotic plaques via induction of autophagy
2016
Recommendations for the use of LDL apheresis
2008
Bladder cancer
2016 Standout
Autophagy in Human Health and Disease
2013 Standout
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
Regulation of the mevalonate pathway
1990 StandoutNature
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Microtubules as a target for anticancer drugs
2004 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Pharmacological Modulation of Cisplatin Toxicity Rhythms with Buthionine Sulfoximine in Mice Bearing Pancreatic Adenocarcinoma (PO3)
1998
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Physiology and molecular biology of petal senescence
2008
B7-H4 overexpression in ovarian tumors
2005
Cancer of the Ovary
2004 Standout
Oxidative stress and apoptosis: a new treatment paradigm in cancer
2006
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action:  Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Sterol-dependent repression of low density lipoprotein receptor promoter mediated by 16-base pair sequence adjacent to binding site for transcription factor Sp1.
1988 StandoutNobel
Serpin Structure, Mechanism, and Function
2002 Standout
Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
2009
Second-Line Treatment of Ovarian Cancer
2000
Autophagy Negatively Regulates Cell Death by Controlling NPR1-Dependent Salicylic Acid Signaling during Senescence and the Innate Immune Response inArabidopsis   
2009 StandoutNobel
Atherosclerosis: Basic Mechanisms
1995 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Clinical Features of Hypersensitivity Reactions to Carboplatin
1999
Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels.
2002
Effects of probucol on xanthomata regression in familial hypercholesterolemia
1986
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 StandoutScienceNobel
Electrochemical Imination of Sulfoxides Using N-Aminophthalimide
2002
Spermidine in health and disease
2018 StandoutScience
Role of Glutathione in Cancer Progression and Chemoresistance
2013
Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer
2016
Biochemical Properties and Crystal Structure of a β-Phenylalanine Aminotransferase from Variovorax paradoxus
2012 StandoutNobel
Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myeloma.
2002
Synthetic Organic Electrochemical Methods Since 2000: On the Verge of a Renaissance
2017 Standout
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
1988 StandoutScience
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
Atg13 HORMA domain recruits Atg9 vesicles during autophagosome formation
2015 StandoutNobel
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates
2014
New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors
1998
Dose escalation study of intravenous estramustine phosphate in combination with Paclitaxel and Carboplatin in patients with advanced prostate cancer.
2003
mTOR: a pharmacologic target for autophagy regulation
2015 Standout
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Tissue-specific expression of B7x protects from CD4 T cell–mediated autoimmunity
2011 StandoutNobel
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
1993 Standout
Three direct repeats and a TATA-like sequence are required for regulated expression of the human low density lipoprotein receptor gene.
1987 StandoutNobel
PLASMA EXCHANGE FOR HYPERCHOLESTEROLAEMIA
1981
Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension.
1995 StandoutNobel
REDOX REGULATION BY INTRINSIC SPECIES AND EXTRINSIC NUTRIENTS IN NORMAL AND CANCER CELLS
2005
Liver Transplantation to Provide Low-Density-Lipoprotein Receptors and Lower Plasma Cholesterol in a Child with Homozygous Familial Hypercholesterolemia
1984 StandoutNobel
Hypoxia Targeted Gene Therapy to Increase the Efficacy of Tirapazamine as an Adjuvant to Radiotherapy
2004

Works of Deborah Kilpatrick being referenced

Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.
1996
Selective Clearance of Macrophages in Atherosclerotic Plaques by Autophagy
2007
Phase I trial of tirapazamine in combination with cisplatin in a single dose every 3 weeks in patients with solid tumors.
1997
Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group.
1996
Evaluation of carboplatin pharmacokinetics in the absence and presence of paclitaxel.
1996
Neoadjuvant accelerated MVAC (AMVAC) in patients with muscle invasive bladder cancer: Results of a multicenter phase II study.
2012
Assessment of long-term plasma exchange for familial hypercholesterolaemia.
1980
Reduction of blood viscosity following plasma exchange
1979
Rankless by CCL
2026